IQVIA Holdings Inc. (IQV) stock
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3014% above fair value
$257.84+0.24 (+0.09%)
Close on Nov 18, 2026Market cap $42.49BP/E 31.3Yield –
Iqvia revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Iqvia's revenue for the twelve months ending Sep 30, 2026 was $17.31B, up 8.8% year over year. For fiscal 2025 it was $16.31B, up 5.9% from the year before. Over ten years it grew 11.0% a year on average. The highest annual figure on record is $16.31B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.31B | +5.9% |
| FY2024 | Dec 31, 2024 | $15.41B | +2.8% |
| FY2023 | Dec 31, 2023 | $14.98B | +4.0% |
| FY2022 | Dec 31, 2022 | $14.41B | +3.9% |
| FY2021 | Dec 31, 2021 | $13.87B | +22.1% |
| FY2020 | Dec 31, 2020 | $11.36B | +2.4% |
| FY2019 | Dec 31, 2019 | $11.09B | +6.5% |
| FY2018 | Dec 31, 2018 | $10.41B | +7.3% |
| FY2017 | Dec 31, 2017 | $9.70B | +42.4% |
| FY2016 | Dec 31, 2016 | $6.82B | +18.8% |
| FY2015 | Dec 31, 2015 | $5.74B | +5.1% |
| FY2014 | Dec 31, 2014 | $5.46B | +7.1% |
| FY2013 | Dec 31, 2013 | $5.10B | +4.8% |
| FY2012 | Dec 31, 2012 | $4.87B | +12.4% |
| FY2011 | Dec 31, 2011 | $4.33B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $4.43B | +8.0% |
| Q2 FY2026 | Jun 30, 2026 | $4.37B | +8.7% |
| Q1 FY2026 | Mar 31, 2026 | $4.15B | +8.4% |
| Q4 FY2025 | Dec 31, 2025 | $4.36B | +10.3% |
| Q3 FY2025 | Sep 30, 2025 | $4.10B | +5.2% |
| Q2 FY2025 | Jun 30, 2025 | $4.02B | +5.3% |
| Q1 FY2025 | Mar 31, 2025 | $3.83B | +2.5% |
| Q4 FY2024 | Dec 31, 2024 | $3.96B | +2.3% |
| Q3 FY2024 | Sep 30, 2024 | $3.90B | +4.3% |
| Q2 FY2024 | Jun 30, 2024 | $3.81B | +2.3% |
| Q1 FY2024 | Mar 31, 2024 | $3.74B | +2.3% |
| Q4 FY2023 | Dec 31, 2023 | $3.87B | +3.5% |
| Q3 FY2023 | Sep 30, 2023 | $3.74B | +4.9% |
| Q2 FY2023 | Jun 30, 2023 | $3.73B | +5.3% |
| Q1 FY2023 | Mar 31, 2023 | $3.65B | +2.4% |
| Q4 FY2022 | Dec 31, 2022 | $3.74B | +2.8% |
| Q3 FY2022 | Sep 30, 2022 | $3.56B | +5.0% |
| Q2 FY2022 | Jun 30, 2022 | $3.54B | +3.0% |
| Q1 FY2022 | Mar 31, 2022 | $3.57B | +4.7% |
| Q4 FY2021 | Dec 31, 2021 | $3.64B | +10.2% |
| Q3 FY2021 | Sep 30, 2021 | $3.39B | +21.7% |
| Q2 FY2021 | Jun 30, 2021 | $3.44B | +36.4% |
| Q1 FY2021 | Mar 31, 2021 | $3.41B | +23.8% |
| Q4 FY2020 | Dec 31, 2020 | $3.30B | +13.9% |
| Q3 FY2020 | Sep 30, 2020 | $2.79B | +0.6% |
| Q2 FY2020 | Jun 30, 2020 | $2.52B | -8.0% |
| Q1 FY2020 | Mar 31, 2020 | $2.75B | +2.6% |
| Q4 FY2019 | Dec 31, 2019 | $2.90B | +7.7% |
| Q3 FY2019 | Sep 30, 2019 | $2.77B | +6.7% |
| Q2 FY2019 | Jun 30, 2019 | $2.74B | +6.7% |
| Q1 FY2019 | Mar 31, 2019 | $2.68B | +4.7% |
| Q4 FY2018 | Dec 31, 2018 | $2.69B | +6.6% |
| Q3 FY2018 | Sep 30, 2018 | $2.59B | +5.2% |
| Q2 FY2018 | Jun 30, 2018 | $2.57B | +9.0% |
| Q1 FY2018 | Mar 31, 2018 | $2.56B | +8.6% |
| Q4 FY2017 | Dec 31, 2017 | $2.52B | +29.1% |
| Q3 FY2017 | Sep 30, 2017 | $2.47B | – |
| Q2 FY2017 | Jun 30, 2017 | $2.36B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.36B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.95B | – |
See a number that looks wrong?